文献速递慢性肾脏病肾血管病与高血压

内脏脂肪组织改变足细胞形态并影响单肾切除后肾脏代偿

Visceral Adipose Tissue Alters Podometrics and Renal Compensation After Uninephrectomy.
PubMed 文献 · Kidney Int Rep · 2025-12-23

本研究回顾性分析52例BMI<30 kg/m2因非转移性肾肿瘤行肾切除术的患者,通过CT量化内脏脂肪组织(VAT),定义内脏肥胖(VO)为VAT面积≥100 cm2。结果显示,35例VO患者肾小球体积更大、足细胞密度更低、足细胞核肥大,且单肾切除后eGFR代偿性下降更明显(ΔeGFR -24 vs -12 ml/min/1.73 m2,P=0.03)。VO与肾小球及足细胞结构改变相关,并损害肾功能代偿。

要点

  • 正常或超重BMI患者中,VAT≥100 cm2与肾小球增大、足细胞密度降低及核肥大相关。
  • VO患者单肾切除后eGFR下降更显著,提示肾脏代偿能力受损。
  • VAT量化可能辅助肾切除术前个体化决策。

核心结论

  • 在BMI正常或超重的个体中,内脏肥胖与肾小球和足细胞改变及肾切除后肾功能代偿受损相关。

研究设计与样本

  • 回顾性研究,纳入52例BMI<30 kg/m2因非转移性肾肿瘤行肾切除术且未接受化疗或免疫治疗的患者,通过CT量化VAT,并利用深度学习支持的组织形态计量学评估足细胞形态。

主要发现

  • 35例诊断为VO(VAT面积≥100 cm2),其肾小球体积显著大于非VO者(2.6 ± 0.7 vs. 2.0 ± 0.5 ×10^6 μm3,P=0.004)。
  • VO组足细胞密度显著降低(194 ± 50 vs. 243 ± 59 per 10^6 μm3,P=0.003),足细胞核体积显著增大(226 ± 27 vs. 195 ± 22 μm3,P<0.001)。
  • VO与单肾切除后eGFR代偿受损相关(ΔeGFR:-24 ± 15 vs. -12 ± 12 ml/min per 1.73 m2,P=0.03)。
  • 肾小球增大(P=0.005)、足细胞密度降低(P=0.01)和核肥大(P=0.003)与ΔeGFR减少显著相关。

关键数值与推荐

  • VO定义为CT测量的VAT面积≥100 cm2。
  • BMI<30 kg/m2被定义为正常或超重。

临床怎么用

  • 对计划行肾切除术的正常或超重BMI患者,可考虑通过CT量化VAT以识别肾脏代偿能力可能受损的高危个体。
  • VO患者术后需更密切监测肾功能代偿情况。

局限性

  • 回顾性研究,样本量较小(52例),结论需前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Obesity is an established risk factor for chronic kidney disease (CKD). However, excess visceral adipose tissue (VAT) termed visceral obesity (VO) can occur in individuals with normal body mass index (BMI) or overweight. VO is associated with impaired kidney function but its effect on kidney morphology remains unclear. This study aimed to examine the association of VO with glomerular ultrastructure, podocyte morphometry (podometrics), and the kidneys' ability for compensation after uninephrectomy in normal BMI and overweight individuals. METHODS: VAT was retrospectively quantified in computed tomography (CT) of 52 patients (BMI < 30 kg/m2) who underwent nephrectomy for nonmetastatic renal tumor without previous chemotherapy or immunotherapy. VO was defined as VAT area ≥ 100 cm2. Histological sections from nontumorous kidney regions were examined using deep learning-supported glomerular morphometry and podometrics (podocyte count, density, and nuclear volume). Renal compensation in the first year after nephrectomy (change in estimated glomerular filtration rate [ΔeGFR]) was assessed using linear regression. RESULTS: Of the 52 subjects with normal BMI or overweight, 35 were diagnosed with VO and exhibited a larger glomerular volume (2.6 ± 0.7 vs. 2.0 ± 0.5 ×106 μm3; P = 0.004), lower podocyte density (194 ± 50 vs. 243 ± 59 per 106 μm3; P = 0.003), and podocyte nuclear hypertrophy (226 ± 27 vs. 195 ± 22 μm3; P < 0.001). VO was associated with impaired eGFR compensation after uninephrectomy (ΔeGFR: -24 ± 15 vs. -12 ± 12 ml/min per 1.73 m2, P = 0.03). Structural changes, including glomerular enlargement (P = 0.005), podocyte density (P = 0.01), and nuclear hypertrophy (P = 0.003), were significantly associated with reduced ΔeGFR. CONCLUSION: VO was associated with glomerular and podocyte changes, and impaired kidney function compensation after nephrectomy in normal BMI and overweight individuals. These data suggest that VAT quantification could guide individual decision making in subjects planned for nephrectomy.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Paschen C, Koeller MC, Hennenberg J, et al. Visceral Adipose Tissue Alters Podometrics and Renal Compensation After Uninephrectomy. Kidney Int Rep. 2025. PMID: 41727777. doi:10.1016/j.ekir.2025.103739

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。